Novo Nordisk to reduce US list prices of insulin products
Pharmaceutical Technology
MARCH 15, 2023
Novo Nordisk has announced plans to reduce the US wholesale acquisition cost (WAC), also known as the list price, of several pre-filled insulin pens and vials by up to 75% for people living with type 1 and type 2 diabetes.
Let's personalize your content